HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Lopaschuk, G. D. Articles by Stanley, W. C. Search for Related Content PubMed PubMed Citation Articles by Lopaschuk, G. D. Articles by Stanley, W. C.

Myocardial Fatty Acid Metabolism in Health and Disease

Cardiovascular Research Group, Mazankowski Alberta Heart Institute, University of Alberta, Alberta, Canada; and Division of Cardiology, Department of Medicine, University of Maryland, Baltimore, Maryland

There is a constant high demand for energy to sustain the continuous contractile activity of the heart, which is met primarily by the β-oxidation of long-chain fatty acids. The control of fatty acid β-oxidation is complex and is aimed at ensuring that the supply and oxidation of the fatty acids is sufficient to meet the energy demands of the heart. The metabolism of fatty acids via β-oxidation is not regulated in isolation; rather, it occurs in response to alterations in contractile work, the presence of competing substrates (i.e., glucose, lactate, ketones, amino acids), changes in hormonal milieu, and limitations in oxygen supply. Alterations in fatty acid metabolism can contribute to cardiac pathology. For instance, the excessive uptake and β-oxidation of fatty acids in obesity and diabetes can compromise cardiac function. Furthermore, alterations in fatty acid β-oxidation both during and after ischemia and in the failing heart can also contribute to cardiac pathology. This paper reviews the regulation of myocardial fatty acid β-oxidation and how alterations in fatty acid β-oxidation can contribute to heart disease. The implications of inhibiting fatty acid β-oxidation as a potential novel therapeutic approach for the treatment of various forms of heart disease are also discussed.

This article has been cited by other articles:

				G. D. Lopaschuk, J. R. Ussher, and J. S. Jaswal Targeting Intermediary Metabolism in the Hypothalamus as a Mechanism to Regulate Appetite Pharmacol. Rev., June 1, 2010; 62(2): 237 - 264. [Abstract] [Full Text] [PDF]

				D. N. Brindley, B. P. C. Kok, P. C. Kienesberger, R. Lehner, and J. R. B. Dyck Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization Am J Physiol Endocrinol Metab, May 1, 2010; 298(5): E897 - E908. [Abstract] [Full Text] [PDF]